We found that NEAT1 inhibition plus DDP in vivo inhibited the BCL-2/caspase-3 levels and increased the BAX expression for tumor apoptosis, and also repressed the cyclin D1/CDK4 expression for cell cycle arrest. Here, BCL2 is linked to neoplasm.